Junling Li
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cutaneous Melanoma Detection and Management
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 128
- Lung Cancer Diagnosis and Treatment 38
- Brain Metastases and Treatment 7
- Oncology 53
- Lung Cancer Research Studies 28
- Cancer Immunotherapy and Biomarkers 20
- Inflammatory Biomarkers in Disease Prognosis 4
- Co-authors
- Puyuan Xing (102 shared papers)Yan Wang (63 shared papers)Xuezhi Hao (79 shared papers)Ziqiang Meng (2 shared papers)Shouzheng Wang (16 shared papers)Ziyi Xu (19 shared papers)Ruijin Li (1 shared paper)Keith B. Glaser (9 shared papers)
- Journals
- Frontiers in Oncology (9 papers)Cancer Medicine (7 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)Lung Cancer (6 papers)Journal of Thoracic Oncology (6 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Junling Li
260 papers receiving 5.6k citations
Junling Li's Hit Papers
Peers
Comparison fields: 5 of 130
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 1.4k
- Cancer Research 285
- Nephrology 135
Countries citing papers authored by Junling Li
This map shows the geographic impact of Junling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junling Li more than expected).
Fields of papers citing papers by Junling Li
This network shows the impact of papers produced by Junling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junling Li. The network helps show where Junling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 274 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 561 | |
| 2 | Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents Hit paper breakdown → | 2020 | 428 |
| 3 | 2006 | 181 | |
| 4 | 2007 | 173 | |
| 5 | 2015 | 163 | |
| 6 | 2021 | 163 | |
| 7 | 2019 | 160 | |
| 8 | 2010 | 135 | |
| 9 | 2002 | 124 | |
| 10 | 2002 | 102 | |
| 11 | 2018 | 96 | |
| 12 | 2016 | 76 | |
| 13 | 2011 | 75 | |
| 14 | 2019 | 73 | |
| 15 | 2011 | 71 | |
| 16 | 2007 | 70 | |
| 17 | 2009 | 68 | |
| 18 | 2012 | 65 | |
| 19 | 2020 | 54 | |
| 20 | 2021 | 54 |
About Junling Li
Junling Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 274 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (128 papers), Lung Cancer Diagnosis and Treatment (38 papers), Lung Cancer Research Studies (28 papers), Cancer Immunotherapy and Biomarkers (20 papers), Brain Metastases and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers), Histone Deacetylase Inhibitors Research (6 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (1.7k citations), Molecular Biology (1.4k citations), Cancer Research (285 citations) and Nephrology (135 citations). Junling Li has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Puyuan Xing, Yan Wang, Xuezhi Hao, Ziqiang Meng, Shouzheng Wang, Ziyi Xu, Ruijin Li, Keith B. Glaser, Steven K. Davidsen and Lori J. Pease. Their work appears in journals such as Frontiers in Oncology, Cancer Medicine, Bioorganic & Medicinal Chemistry Letters, Lung Cancer and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.